Skip to content

Effect of Whole Body Vibration on Walking Performance in Elderly Hemodialysis Patients

A Randomized Controlled Trial to Evaluate the Efficacy of Whole Body Vibration on Walking Performance in Elderly Hemodialysis Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04774731
Enrollment
98
Registered
2021-03-01
Start date
2021-04-01
Completion date
2022-03-30
Last updated
2022-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis

Keywords

whole body vibration, hemodialysis, gait function

Brief summary

The purpose of this study is to evaluate the efficacy of whole body vibration for 12 weeks on walking performance in elderly hemodialysis patients.

Detailed description

This is a multicenter, prospective, randomized controlled trial. Eligible subjects will be randomized in a 1:1 ratio to a whole-body vibration (WBV) group or controlled group. Patients in a WBV group will receive WBV training three times a week before initiation of dialysis sessions for 12 weeks. The primary outcome of the study will be the change in walking performance assessed by the timed up and go test.

Interventions

OTHERWhole Body Vibration

Receiving WBV training three times a week before initiation of dialysis sessions for 12 weeks. Subjects stand on a platform of WBV for 3 minutes in every training session.

Sponsors

Osaka University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Undergoing maintenance hemodialysis three times a week .

Exclusion criteria

* Having difficulty in walking by oneself. * Having difficulty in receiving whole body vibration training because of cognitive impairment. * History of fracture of lower limb within 1 year. * History of total hip arthroplasty. * Unsuitable for participant in the trial by an attending physician.

Design outcomes

Primary

MeasureTime frame
Change in the timed up and go test12 weeks after starting intervention

Secondary

MeasureTime frame
Change in the one-leg standing test12 weeks after starting intervention
Change in the 30-second chair-stand test12 weeks after starting intervention

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026